CONFIRMATION OF ASSOCIATION OF HLA-DRB1*13 WITH UVEITIS IN JUVENILE IDIOPATHIC ARTHRITIS

CONFIRMATION OF ASSOCIATION OF HLA-DRB1*13 WITH UVEITIS IN JUVENILE IDIOPATHIC ARTHRITIS

Bibliografski detalji
Glavni autori:	Zeggini, E, Thomson, W, Wordsworth, P, Hall, M, Packham, J
Format:	Journal article
Izdano:	2004

Slični predmeti

Association of HLA-DRB1*13 with susceptibility to uveitis in juvenile idiopathic arthritis in two independent data sets.
od: Zeggini, E, i dr.
Izdano: (2006)

Systemic juvenile idiopathic arthritis is associated with <it>HLA-DRB1</it> in Europeans and Americans of European descent
od: Ombrello Michael, i dr.
Izdano: (2012-07-01)

PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis.
od: Kaori Hisa, i dr.
Izdano: (2017-01-01)

Juvenile Idiopathic Arthritis Associated Uveitis
od: Emil Carlsson, i dr.
Izdano: (2021-07-01)

Juvenile idiopathic arthritis-associated uveitis
od: Matej Krišto, i dr.
Izdano: (2023-01-01)

Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis
od: İlknur Tuğal-Tutkun
Izdano: (2016-04-01)

The Role of Gender in Juvenile Idiopathic Arthritis-Associated Uveitis
od: Ahmadreza Moradi, i dr.
Izdano: (2014-01-01)

Protective role of HLA-DRB1*11 against juvenile idiopathic arthritis living in North Eastern Iran
od: Zahra Rezaieyazdi, i dr.
Izdano: (2018-06-01)

Investigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlap.
od: Hinks, A, i dr.
Izdano: (2012)

Impact of Juvenile Idiopathic Arthritis Associated Uveitis in Early Adulthood.
od: Anne-Mieke J W Haasnoot, i dr.
Izdano: (2016-01-01)

Spontaneous hyphema in juvenile idiopathic arthritis uveitis
od: Figen Bezci Aygun, i dr.
Izdano: (2023-02-01)

Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
od: Aysha Chaudhary, i dr.
Izdano: (2023-10-01)

Recent advances in the treatment of juvenile idiopathic arthritis–associated uveitis
od: Judy L. Chen, i dr.
Izdano: (2021-02-01)

Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
od: Sofia Lanz, i dr.
Izdano: (2021-08-01)

HLA-DRB1*01 predicts treatment outcome in juvenile idiopathic arthritis: A retrospective-prospective cohort study
od: Adisa Čengić, i dr.
Izdano: (2024-10-01)

Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis.
od: Hall, F, i dr.
Izdano: (1996)

Identification of Ocular Autoantigens Associated With Juvenile Idiopathic Arthritis-Associated Uveitis
od: Martin Busch, i dr.
Izdano: (2019-08-01)

Idiopathic uveitis presents different characteristics and outcome from juvenile idiopathic arthritis- related uveitis
od: Renata Lopes Francisco de Andrade, i dr.
Izdano: (2024-04-01)

Idiopathic intracranial hypertension with juvenile idiopathic arthritis‐associated uveitis: A case report
od: Asaad Alkoht, i dr.
Izdano: (2021-06-01)

Usefulness of Adalimumab in the Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
od: Carmen García-De-Vicuña, i dr.
Izdano: (2013-01-01)

Clinical characteristics and risk factors of juvenile idiopathic arthritis-associated uveitis
od: ZHANG Yan, i dr.
Izdano: (2024-10-01)

Psoriatic Juvenile Idiopathic Arthritis Associated with Uveitis: A Case Report
od: Davide Moretti, i dr.
Izdano: (2013-01-01)

Chinese Expert Consensus on Juvenile Idiopathic Arthritis-associated Uveitis (2023)
od: The Subspecialty Group of Immunology, the Society of Pediatrics, Chinese Medical Association, i dr.
Izdano: (2023-03-01)

Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis, a Narrative Review
od: Claudia Iannone, i dr.
Izdano: (2023-02-01)

Investigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlap
od: Hinks, A, i dr.
Izdano: (2012)

Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
od: Julie Molimard, i dr.
Izdano: (2021-09-01)

EFFICACY OF ADALIMUMAB IN A PATIENT WITH JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS
od: L. A. Galstyan, i dr.
Izdano: (2012-11-01)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
od: Alpigiani MG, i dr.
Izdano: (2008-09-01)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
od: Bracaglia C, i dr.
Izdano: (2008-09-01)

Anti-TNF therapy for juvenile idiopathic arthritis-related uveitis
od: Semeraro F, i dr.
Izdano: (2014-03-01)

Identification of novel autoantigens as potential biomarkers in juvenile idiopathic arthritis associated uveitis
od: Sabine Arve-Butler, i dr.
Izdano: (2023-01-01)

Granulomatous Features in Juvenile Idiopathic Arthritis-Associated Uveitis is Not a Rare Occurrence
od: Papasavvas I, i dr.
Izdano: (2021-03-01)

Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis
od: Kotaniemi K, i dr.
Izdano: (2011-10-01)

Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
od: Nisha R. Acharya, i dr.
Izdano: (2020-10-01)

Replication of the association of the <it>COG6</it> gene with juvenile idiopathic arthritis (JIA)
od: Worthington J, i dr.
Izdano: (2011-09-01)

Uveitis in patients with oligoarticular juvenile idiopathic arthritis and juvenile spondyloarthritis/enthesitis related arthritis: is there any difference?
od: A. Martins, i dr.
Izdano: (2023-05-01)

MHC class III genes in rheumatoid arthritis and the differential association of HLA-DRB1 alleles with disease
od: Harney, S, i dr.
Izdano: (2005)

Severe Macular Edema in Patients with Juvenile Idiopathic Arthritis-Related Uveitis
od: Maria Pia Paroli, i dr.
Izdano: (2013-01-01)

TREATMENT APPROACH FOR JUVENILE IDIOPATHIC ARTHRITIS-RELATED UVEITIS: 2012 UPDATE
od: Francesco Zulian, i dr.
Izdano: (2012-09-01)

EFFICACY AND SAFETY OF PEDIATRIC JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS TREATMENT WITH ADALIMUMAB
od: E. I. Alexeeva, i dr.
Izdano: (2012-01-01)